Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Johnson

Showing results (141-150 of 177) with videos related to

Pageof 18
Sort By:
Current Medical Research and Opinion|November 26, 2005
Do strong opioids have a role in the early management of back pain? Recommendations from a European expert panelEija Kalso, Laurie Allan, Jan Dobrogowski, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 10, 2003
Neuronal repellent Slit2 inhibits dendritic cell migration and the development of immune responsesHongbing Guan, Guorui Zu, Yi Xie, et al.
Pharmaceutical Research|May 6, 2014
Dopamine D2 receptor occupancy as a predictor of catalepsy in rats: a pharmacokinetic-pharmacodynamic modeling approachMartin Johnson, Magdalena Kozielska, Venkatesh Pilla Reddy, et al.
Schizophrenia Research|March 12, 2013
Pharmacokinetic-pharmacodynamic modelling of antipsychotic drugs in patients with schizophrenia: part II: the use of subscales of the PANSS scoreVenkatesh Pilla Reddy, Magdalena Kozielska, Ahmed Abbas Suleiman, et al.
Pharmaceutical Research|January 1, 2016
Translational Modeling in Schizophrenia: Predicting Human Dopamine D2 Receptor OccupancyMartin Johnson, Magdalena Kozielska, Venkatesh Pilla Reddy, et al.
Pharmaceutical Research|March 12, 2016
Erratum to: Translational Modeling in Schizophrenia: Predicting Human Dopamine D₂ Receptor OccupancyMartin Johnson, Magdalena Kozielska, Venkatesh Pilla Reddy, et al.
Schizophrenia Research|March 12, 2013
Pharmacokinetic-pharmacodynamic modeling of antipsychotic drugs in patients with schizophrenia Part I: the use of PANSS total score and clinical utilityVenkatesh Pilla Reddy, Magdalena Kozielska, Ahmed Abbas Suleiman, et al.
Clinical Pharmacokinetics|March 17, 2012
Modelling and simulation of the Positive and Negative Syndrome Scale (PANSS) time course and dropout hazard in placebo arms of schizophrenia clinical trialsVenkatesh Pilla Reddy, Magdalena Kozielska, Martin Johnson, et al.
Clinical Pharmacology and Therapeutics|November 27, 2023
Longitudinal Circulating Tumor DNA Modeling to Predict Disease Progression in First-Line Mutant Epidermal Growth Factor Receptor Non-Small Cell Lung CancerMartin Johnson, Carlos Serra Traynor, Karthick Vishwanathan, et al.
Regenerative Therapy|July 25, 2024
Sustainably cultured coral scaffold supports human bone marrow mesenchymal stromal cell osteogenesisChiara Gentili, Maria Elisabetta Federica Palamà, Gillian Sexton, et al.
Pageof 18

Showing results (141-150 of 177) with videos related to

Sort By:
Pageof 18
Current Medical Research and Opinion|November 26, 2005
Do strong opioids have a role in the early management of back pain? Recommendations from a European expert panelEija Kalso, Laurie Allan, Jan Dobrogowski, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 10, 2003
Neuronal repellent Slit2 inhibits dendritic cell migration and the development of immune responsesHongbing Guan, Guorui Zu, Yi Xie, et al.
Pharmaceutical Research|May 6, 2014
Dopamine D2 receptor occupancy as a predictor of catalepsy in rats: a pharmacokinetic-pharmacodynamic modeling approachMartin Johnson, Magdalena Kozielska, Venkatesh Pilla Reddy, et al.
Schizophrenia Research|March 12, 2013
Pharmacokinetic-pharmacodynamic modelling of antipsychotic drugs in patients with schizophrenia: part II: the use of subscales of the PANSS scoreVenkatesh Pilla Reddy, Magdalena Kozielska, Ahmed Abbas Suleiman, et al.
Pharmaceutical Research|January 1, 2016
Translational Modeling in Schizophrenia: Predicting Human Dopamine D2 Receptor OccupancyMartin Johnson, Magdalena Kozielska, Venkatesh Pilla Reddy, et al.
Pharmaceutical Research|March 12, 2016
Erratum to: Translational Modeling in Schizophrenia: Predicting Human Dopamine D₂ Receptor OccupancyMartin Johnson, Magdalena Kozielska, Venkatesh Pilla Reddy, et al.
Schizophrenia Research|March 12, 2013
Pharmacokinetic-pharmacodynamic modeling of antipsychotic drugs in patients with schizophrenia Part I: the use of PANSS total score and clinical utilityVenkatesh Pilla Reddy, Magdalena Kozielska, Ahmed Abbas Suleiman, et al.
Clinical Pharmacokinetics|March 17, 2012
Modelling and simulation of the Positive and Negative Syndrome Scale (PANSS) time course and dropout hazard in placebo arms of schizophrenia clinical trialsVenkatesh Pilla Reddy, Magdalena Kozielska, Martin Johnson, et al.
Clinical Pharmacology and Therapeutics|November 27, 2023
Longitudinal Circulating Tumor DNA Modeling to Predict Disease Progression in First-Line Mutant Epidermal Growth Factor Receptor Non-Small Cell Lung CancerMartin Johnson, Carlos Serra Traynor, Karthick Vishwanathan, et al.
Regenerative Therapy|July 25, 2024
Sustainably cultured coral scaffold supports human bone marrow mesenchymal stromal cell osteogenesisChiara Gentili, Maria Elisabetta Federica Palamà, Gillian Sexton, et al.
Pageof 18